Compare SLQT & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLQT | LFCR |
|---|---|---|
| Founded | 1999 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 281.6M | 296.0M |
| IPO Year | 2020 | N/A |
| Metric | SLQT | LFCR |
|---|---|---|
| Price | $1.51 | $7.82 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 3 |
| Target Price | $3.88 | ★ $6.00 |
| AVG Volume (30 Days) | ★ 864.0K | 145.9K |
| Earning Date | 11-06-2025 | 01-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,563,142,000.00 | $128,867,000.00 |
| Revenue This Year | $13.00 | $2.80 |
| Revenue Next Year | $7.65 | $11.51 |
| P/E Ratio | $12.04 | ★ N/A |
| Revenue Growth | ★ 13.16 | 0.47 |
| 52 Week Low | $1.33 | $4.76 |
| 52 Week High | $6.86 | $8.85 |
| Indicator | SLQT | LFCR |
|---|---|---|
| Relative Strength Index (RSI) | 47.74 | 57.87 |
| Support Level | $1.38 | $7.34 |
| Resistance Level | $1.50 | $7.87 |
| Average True Range (ATR) | 0.07 | 0.26 |
| MACD | 0.03 | -0.02 |
| Stochastic Oscillator | 75.00 | 83.06 |
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.